InflaRx N.V. Reports 2024 Results and Milestones
Ticker: IFRX · Form: 6-K · Filed: Mar 20, 2025 · CIK: 1708688
Sentiment: neutral
Topics: results, milestones, press-release
TL;DR
InflaRx dropped its 2024 results and future plans on 3/20/25.
AI Summary
On March 20, 2025, InflaRx N.V. (the "Company") issued a press release reporting its full-year 2024 results and highlighting key achievements and expected milestones. The press release, attached as Exhibit 99.1 to this Form 6-K, provides an update on the company's progress.
Why It Matters
This filing provides investors with an update on InflaRx's financial performance and strategic progress for the full year 2024, including future milestones.
Risk Assessment
Risk Level: low — This is a routine filing reporting past results and future expectations, not indicating immediate operational or financial distress.
Key Players & Entities
- InflaRx N.V. (company) — Registrant
- March 20, 2025 (date) — Date of press release
- 2024 (date) — Fiscal year reported
- Exhibit 99.1 (document) — Attached press release
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report a press release issued by InflaRx N.V. on March 20, 2025, titled 'InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones.'
When was the press release attached to this filing issued?
The press release was issued on March 20, 2025.
What period do the reported results in the press release cover?
The reported results cover the full year 2024.
Is the attached press release considered 'filed' for the purposes of Section 18 of the Exchange Act?
No, Exhibit 99.1 shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise.
What is the company's principal executive office address?
The company's principal executive office is located at Winzerlaer Str. 2, 07745 Jena, Germany.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 20, 2025 regarding InflaRx N.V. (IFRX).